Vertex Pharmaceuticals Inc
NASDAQ: VRTX
$493.64
-$6.24 (-1.2%)
Closing Price on November 6, 2024
VRTX Articles
Jon OggNow that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which stocks they should still buy and which stocks they should sell or avoid. 24/7...
Published:
ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have already made big...
Published:
Last Updated:
ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company...
Published:
Last Updated:
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems like an...
Published:
Last Updated:
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Wednesday, May 29, 2013. They include Comerica, Maxim Integrated, Vertex Pharmaceuticals and...
Published:
Last Updated:
ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28%...
Published:
Last Updated:
thinkstockHere are today’s five biggest gaining stocks at closing: Vertex Pharmaceuticals Inc.(NASDAQ: VRTX) is up 61.9% at $85.60. Desarrolladora Homex (NYSE: HMX) is up 40.2% at $8.16. Novadaq...
Published:
Last Updated:
U.S. equity markets opened mixed this morning as the DJIA was slammed by a number of weak earnings reports both last night and before markets opened this morning. The was no economic data out in Asia...
Published:
Last Updated:
Investors and traders are usually always on the hunt for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh analyst research calls to find great...
Published:
Last Updated:
Jon OggInvestors and traders remain on the lookout for new ideas for profits and income. 24/7 Wall St. looks over numerous research calls to find great ideas from value stocks to growth stocks to...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that is...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. Check Point Software Technologies Ltd. (NASDAQ: CHKP) started as Market...
Published:
Last Updated:
The research team at Argus Research is making some changes to its theoretical model portfolios. It is making buy and sell recommendations in the Equity Income, Growth & Income and Mid-Cap Growth...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Alcatel-Lucent S.A. (NYSE: ALU) maintained Underperform at BofA/ML and maintained...
Published:
Last Updated:
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena...
Published: